Assetmark, Inc Oric Pharmaceuticals, Inc. Transaction History
Assetmark, Inc
- $45.6 Billion
- Q3 2025
A detailed history of Assetmark, Inc transactions in Oric Pharmaceuticals, Inc. stock. As of the latest transaction made, Assetmark, Inc holds 3,089 shares of ORIC stock, worth $38,458. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,089Holding current value
$38,458% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ORIC
# of Institutions
151Shares Held
92MCall Options Held
1.03MPut Options Held
10.1K-
Nextech Invest, Ltd. Zurich, V87.16MShares$89.2 Million13.76% of portfolio
-
Vr Adviser, LLC New York, NY6.6MShares$82.1 Million13.26% of portfolio
-
Viking Global Investors LP6.57MShares$81.8 Million0.21% of portfolio
-
Nextech Invest Ag5.29MShares$65.8 Million7.95% of portfolio
-
Black Rock Inc. New York, NY4.83MShares$60.1 Million0.0% of portfolio
About Oric Pharmaceuticals, Inc.
- Ticker ORIC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,576,700
- Market Cap $493M
- Description
- ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...